Desert Clinical Research

Mesa, Arizona 85213

1 studies enrolling now · 14 studies all time

What they study most

Acute Migraine, Acute Otitis Media, COVID-19, Diabetes Mellitus, Type 2, Erectile Dysfunction, Hyperlipidemia, Migraine Disorders, NASH - Nonalcoholic Steatohepatitis, Obesity, SARS-CoV-2, SARS-CoV2, T2DM

Studies at this site

• Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus — Recruiting now
• A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection — Running, not enrolling
• A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19) — Running, not enrolling
• Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE) — Running, not enrolling
• Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight — Running, not enrolling
• Project REMOTE (REimagining Measurements and Operations of Translational Endpoints) — Running, not enrolling
• A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus — Completed
• Four Arm Safety & Efficacy With Antipyrine and Benzocaine Otic Solution in Children With Acute Otitis Media — Completed
• An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine — Completed
• Lasmiditan Compared to Placebo in the Acute Treatment of Migraine: — Completed
• A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol — Stopped early
• A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c — Stopped early
• Vardenafil Orodispersible Tablet (ODT) Versus Placebo in Males With Erectile Dysfunction, 50% of Whom Are to be 65 Years or Older. — Completed